Advances in the Diagnosis and Treatment of Mycobacterial Infections

Dear Colleagues,

Mycobacterial infections—including tuberculosis (TB), latent tuberculosis infection (LTBI), and nontuberculous mycobacterial (NTM) diseases—remain significant global health challenges, with the emergence of drug resistance and complex host–pathogen interactions complicating clinical management. Recent advances in molecular diagnostics, genomics, host immune profiling, and pharmacologic development offer new opportunities to improve early detection, understand transmission dynamics, and enhance therapeutic strategies.

This Special Issue aims to bring together cutting-edge research and critical reviews that highlight novel approaches in the diagnosis and treatment of mycobacterial infections. We welcome original research and comprehensive review articles addressing a wide range of topics, including but not limited to: genetic and phenotypic characterization of Mycobacterium tuberculosis and NTM species, mechanisms of drug resistance and tolerance, host–pathogen interactions, host immunity, innovative diagnostic tools, and the development and evaluation of new treatment regimens.

We particularly encourage submissions that bridge basic, translational, and clinical research, as well as those that explore interdisciplinary approaches combining microbiology, immunology, pharmacology, and public health.

To advance the field and foster collaboration among researchers, clinicians, and public health experts, we invite you to contribute your latest findings or perspectives to this Special Issue. Together, we hope to deepen our understanding and improve outcomes for patients affected by mycobacterial diseases.

We look forward to your valuable contributions.

Dr. Hung-Ling Huang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.